vedolizumab,ustekinumab
takeda,janssen
['vedolizumab', ' vedo', 'vedo', 'crohn', 'ustekinumab']
collaboration with in preventing luminal and perianal fistulizing complications in #crohnsdisease using marketscan database comparing anti-tnfs to ustekinumab and vedolizumab #ddw2023 
Assoc Professor, Director Clinical/Translational Research @WUGastro @IbdWustl, AE @IBDJournals, Deputy Director, SPARC-IBD, via @OfficialJipmer @MayoClinicGIHep